BNP PARIBAS FINANCIAL MARKETS - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 109 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,069
-99.9%
6,108
+236.7%
0.00%
Q3 2022$787,000
-81.1%
1,814
-62.9%
0.00%
Q2 2022$4,165,000
-98.6%
4,896
-91.2%
0.00%
Q1 2022$307,375,000
+89.2%
55,785
+232.3%
0.00%
Q4 2021$162,498,000
+6.9%
16,787
+97.5%
0.00%
Q3 2021$151,944,000
+242.0%
8,498
+366.9%
0.00%
Q2 2021$44,426,000
-87.3%
1,820
-86.3%
0.00%
-100.0%
Q1 2021$350,886,000
+435.6%
13,241
+53.4%
0.00%
Q4 2020$65,517,000
+35.6%
8,632
-10.5%
0.00%
Q3 2020$48,326,000
+210.9%
9,646
+271.1%
0.00%
Q2 2020$15,542,000
-69.7%
2,599
-77.4%
0.00%
Q1 2020$51,277,000
+12.5%
11,523
+140.3%
0.00%
Q4 2019$45,562,000
-6.8%
4,796
-23.0%
0.00%
Q3 2019$48,906,000
-31.9%
6,230
+36.5%
0.00%
Q2 2019$71,792,000
-47.0%
4,564
-39.0%
0.00%
Q1 2019$135,478,000
+21507.3%
7,485
+19092.3%
0.00%
Q4 2018$627,000
-49.8%
39
-25.0%
0.00%
Q3 2018$1,248,000520.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,296,526$290,671,0005.29%
HARBOURVEST PARTNERS LLC 986,878$7,490,0002.93%
Abbot Financial Management, Inc. 537,000$4,076,0002.35%
Artal Group S.A. 3,778,913$28,682,0000.62%
HITE Hedge Asset Management LLC 88,740$674,0000.16%
Virtus ETF Advisers LLC 33,793$256,0000.11%
JACOBS LEVY EQUITY MANAGEMENT, INC 394,909$2,997,0000.03%
Baillie Gifford 4,710,061$35,749,0000.02%
Caption Management, LLC 86,000$652,0000.02%
Blueshift Asset Management, LLC 14,626$111,0000.01%
View complete list of RUBIUS THERAPEUTICS INC shareholders